Corrigendum to “Design, structure–activity relationship, and highly efficient asymmetric synthesis of 3-phenyl-4-benzylaminopiperidine derivatives as novel neurokinin-1 receptor antagonists” [Bioorg. Med. Chem. 19 (2011) 6430–6446]